NRXP

NRX Pharmaceuticals, Inc. Common Stock

2.12

USD

NRXP Earnings Reports

Positive Surprise Ratio

NRXP beat 7 of 14 last estimates.

50%

Next Report

Date of Next Report

Mar 16, 2026

Estimate for Q4 25 (Revenue/ EPS)

$7.68M

$0.00

Implied change from Q3 25 (Revenue/ EPS)

+3071.69%

-100.00%

Implied change from Q4 24 (Revenue/ EPS)

-100.00%

NRX Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, NRXP reported earnings of -0.50 USD per share (EPS) for Q3 25, missing the estimate of -0.08 USD, resulting in a -476.70% surprise. Revenue reached 242.00 thousand, compared to an expected 6.96 million, with a -96.52% difference. The market reacted with a -15.26% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 7.68 million USD, implying an decrease of -100.00% EPS, and increase of 3071.69% in Revenue from the last quarter.

FAQ

What were NRX Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, NRX Pharmaceuticals, Inc. Common Stock reported EPS of -$0.50, missing estimates by -476.7%, and revenue of $242.00K, -96.52% below expectations.

How did the market react to NRX Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -15.26%, changed from $2.49 before the earnings release to $2.11 the day after.

When is NRX Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 16, 2026.

What are the forecasts for NRX Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 6 analysts, NRX Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of $7.68M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.